Modification of prescribers’ behavior: the Icelandic approach

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990  Niels Frimodt-Møller, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl 
R. Leclercq  Clinical Microbiology and Infection 
Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non- European’ strains  Irina S. Koroleva, Alexander E. Platonov, Arie van.
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Approach to diagnosis of infective endocarditis
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Herpes zoster in non-hospitalized children
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre.
Bernard Grenier  Clinical Microbiology and Infection 
Didier Guillemot, Claude Carbon  Clinical Microbiology and Infection 
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
Carriage and antibiotic resistance of respiratory pathogens and molecular epidemiology of antibiotic-resistant Streptococcus pneumoniae colonizing children.
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca  N. Moustaoui,
Structure of grepafloxacin relative to activity and safety profile
D.E. Low  Clinical Microbiology and Infection 
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage  Ron Dagan, Drora Fraser, Noga Givon, Pablo.
Training for the infectious diseases speciality in Norway
Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period  P. Harris, D.-A. Siew, M. Proud, P. Buettner,
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro 
Sepsis and neutropenia induced by clozapine
Antibiotic usage and the incidence of resistance
Uncommon opportunistic fungi: new nosocomial threats
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
Community-acquired pneumonia: epidemiologic and clinical consideration
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
Training in infectious diseases and tropical medicine in Britain
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990  Niels Frimodt-Møller, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl 
Overview of cefixime use in community-acquired infections
Brita Bruun, Henrik Westh, Jørgen Stenderup 
Sanford Chodosh  Clinical Microbiology and Infection 
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Typing of Clostridium difficile
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Fernando Baquero, John F
Assessment of the BacT/Alert blood culture system: rapid bacteremia diagnosis with loading throughout the 24 h  Jonas Bengtsson, Martin Wahl, Peter Larsson 
Presentation transcript:

Modification of prescribers’ behavior: the Icelandic approach Karl G. Kristinsson  Clinical Microbiology and Infection  Volume 5, Pages 4S43-4S47 (August 1999) DOI: 10.1111/j.1469-0691.1999.tb00856.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Yearly incidence rates for penicillin-non-susceptible pneumococci isolated from patient specimens. Repeat isolates have been excluded. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Quarterly incidence of penicillin-non-susceptible pneumococci of serogroups 6, 19 and 23. The values for serogroup 19 strains also include strains with penicillin MIC of 0.06 mg/L. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Proportion of children carrying pneumococci according to age. The open columns represent pneumococcal carriage, and the shaded columns carriage of penicillin-non-susceptible strains. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 Antimicrobial use in defined daily dosages (DDD) per 1000 inhabitants per day in Iceland. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions